title: BCR/ABL fusion gene detected in acute promyelocytic leukemia: a case study of clinical and laboratory results.
authors.affiliation: Beijing Hightrustcorp Diagnosis , Beijing , China.
authors.forename: Xiaolin
authors.initials: X
authors.lastname: Sun
authors.forename: Yanli
authors.initials: Y
authors.lastname: He
authors.forename: Cui
authors.initials: C
authors.lastname: Mao
authors.forename: Liwen
authors.initials: L
authors.lastname: Zhu
authors.forename: Xiaoming
authors.initials: X
authors.lastname: Qin
authors.forename: Shiang
authors.initials: S
authors.lastname: Huang
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000008:administration & dosage; D001549:Benzamides / Q000008:administration & dosage; D002884:Chromosomes, Human, Pair 15 / Q000235:genetics; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics; D002892:Chromosomes, Human, Pair 22 / Q000235:genetics; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006801:Humans; D000068877:Imatinib Mesylate; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D015473:Leukemia, Promyelocytic, Acute / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D010087:Oxides / Q000008:administration & dosage; D010879:Piperazines / Q000008:administration & dosage; D011743:Pyrimidines / Q000008:administration & dosage; D014178:Translocation, Genetic; D016896:Treatment Outcome; D014212:Tretinoin / Q000008:administration & dosage
chemical_list: D001152:Arsenicals; D001549:Benzamides; D010087:Oxides; D010879:Piperazines; D011743:Pyrimidines; D014212:Tretinoin; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl; D000077237:Arsenic Trioxide